Pay to Marwadi

Company Profile

SHUKRA PHARMACEUTICALS LTD.

NSE : NABSE : 524632ISIN CODE : INE551C01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE103.052.02 (+2 % )
PREV CLOSE (Rs.) 101.03
OPEN PRICE (Rs.) 103.05
BID PRICE (QTY) 103.05 (11189 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 11674
TODAY'S LOW / HIGH (Rs.)103.05 103.05
52 WK LOW / HIGH (Rs.) 20.43 101.03
NSE
This Company is not listed in NSE

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.49
TTM EPS (Rs.) 4.23
P/E Ratio 24.35
Book Value (Rs.) 19.76
Face Value (Rs.) 10
MCap (Rs. in Mn) 4512.35
Price/Earning (TTM) 21.94
Price/Sales (TTM) 4.10
Price/Book (MRQ) 5.22
PAT Margin (%) 7.49
ROCE (%) 18.85
Incorporation Year : 1993

Management Info :

Dakshesh Shah - Chairman Dakshesh Shah - Managing Director

Registered Office :

Address : 3rd Floor, Veer House,Opp Wiaa Office ,Judges Bunglow Road Bodakdev,
Ahmedabad,
Gujarat-380054

Phone : 079-27498515

Registrar's Details : Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, Ahmedabad
NEWS More
05Apr04-05-2024$Shukra Pharmaceuticals informs about disclosure Shukra Pharmaceuticals infor
Shukra Pharmaceuticals has informed that the Shareholders through postal ballot have approved the alteration to clause 5 of the Memorandum of Association (MOA) of the company. And article clause no,3B(ii)(d) of Article of Association(AoA) of the company Accordingly, the MOA of the Company has been altered as follows: The Authorized Share capital of the company is Rs 44,00,00,000 (Rupees Forty-four crore only) consisting of 4,40,0d,000 (Four Crore Forty Lakh) Equity Shares of Rs 10 each.’

The above information is a part of company’s filings submitted to BSE.

Shukra Pharmaceuticals has informed that the Shareholders throu..
05Apr04-05-2024$Shukra Pharmaceuticals informs about outcome of postal ballot Shukra Pharmaceuticals infor
Shukra Pharmaceuticals has informed that it enclosed the details of voting results of postal ballot along with the Scrutinizers Report on Postal ballot received and on remote e-voting during the period between Tuesday, March 05, 2024 at 09.00 am (IST) and end on Wednesday, April 03, 2024 at 05.00 pm (IST) (inclusive of both days). The resolution mentioned in the Postal Ballot Notice dated February29, 2024 deemed to be passed on the on the last date specified for voting April 03, 2024.

The above information is a part of company’s filings submitted to BSE.

Shukra Pharmaceuticals has informed that it enclosed the detail..
05Apr04-05-2024$Shukra Pharmaceuticals submits scrutinizer’s report Shukra Pharmaceuticals submi
Shukra Pharmaceuticals has informed that it enclosed Scrutinizer's Report on Postal Ballot process conducted through electronic voting system in accordance with the provisions of Section 108 and Section 110 and other applicable provisions, if any of the Companies Act, 2013 read with Rule 20 and Rule 22 of Companies (Management and Administration) Rules, 2014, as amended.

The above information is a part of company’s filings submitted to BSE.

Shukra Pharmaceuticals has informed that it enclosed Scrutinize..
29Feb02-29-2024$Allotment of Equity Shares Allotment of Equity Shares
Bonus Issue Inter alia, considered and approved the following items: 1. Issue of Bonus Shares in the proportion of 3: 1i.e. 3 [Three) fully paid-up bonus Equity share of Rs. 10/- [Rupees Ten only) each for every 1 (0ne) I'ully paid-up uity share of Rs. 10/- [Rupees Ten only) each held by the Members of the pany as on the Record Date, subject to approval of Members of the Company rough Postal Ballot. 2. Increase in Authorize share capital of the company from l-2,00,00,000/- [Rupees Twelve Crore to 44,00,00,000/-(Rupees Forty-four Crore) by altering the capital clause of Memorandum of Association of the company subject to approval of Members of the company through Postal Ballot. 3. Amend the Article 38[ii)[d) of Article of Association of the company by altering the capital clause of Article of Association of the company subject to approval of Members of the company through Postal Ballot. 4. Approve the revision in remuneration of Mr. Dakshesh Shah, Chairman Cum Managing Director of the company. 5. Approved postal ballot notice for seeking consent of Members of the Company for the Resolutions as set out in the postal ballot Notice and other matters incidental thereto.
Bonus Issue Inter alia, considered and approved the following..
29Feb02-29-2024$Notice of Postal Ballot Notice of Postal Ballot
Bonus Issue Inter alia, considered and approved the following items: 1. Issue of Bonus Shares in the proportion of 3: 1i.e. 3 [Three) fully paid-up bonus Equity share of Rs. 10/- [Rupees Ten only) each for every 1 (0ne) I'ully paid-up uity share of Rs. 10/- [Rupees Ten only) each held by the Members of the pany as on the Record Date, subject to approval of Members of the Company rough Postal Ballot. 2. Increase in Authorize share capital of the company from l-2,00,00,000/- [Rupees Twelve Crore to 44,00,00,000/-(Rupees Forty-four Crore) by altering the capital clause of Memorandum of Association of the company subject to approval of Members of the company through Postal Ballot. 3. Amend the Article 38[ii)[d) of Article of Association of the company by altering the capital clause of Article of Association of the company subject to approval of Members of the company through Postal Ballot. 4. Approve the revision in remuneration of Mr. Dakshesh Shah, Chairman Cum Managing Director of the company. 5. Approved postal ballot notice for seeking consent of Members of the Company for the Resolutions as set out in the postal ballot Notice and other matters incidental thereto.
Bonus Issue Inter alia, considered and approved the following..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit94.244.0599999999999
Gross Profit 95.28 44.4099999999999
Operating Profit 101.0665.5999999999999
Net Sales 188.91588.34
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 25868.05 (0.59%)
M.Cap ( in Cr)
54882.27
Neuland Laboratories (BSE)
 7450.00 (1.28%)
M.Cap ( in Cr)
9513.23
Astrazeneca Pharma I (BSE)
 5267.30 (1.16%)
M.Cap ( in Cr)
13116.75
AMI Organics (BSE)
 1208.00 (4.17%)
M.Cap ( in Cr)
4448.53
Albert David (BSE)
 1137.80 (3.62%)
M.Cap ( in Cr)
645.48
Shareholding Pattern More
PROMOTERS 50.96 %
NON-INSTITUTION 48.93 %
FI/BANKS/INSURANCE 0.11 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes